急性心肌梗死(非溶栓者)中医药抢救新方案疗效观察  

Clinical Observation on the Treatment of AMI(Non-Thrombolytic)with TCM in the New Routine Emergeny Plam

作　　者：黄永生[1] 刘爱东[1] 

机构地区：[1]长春中医学院附属医院,长春130021

出　　处：《中国中医急症》2003年第4期289-290,共2页Journal of Emergency in Traditional Chinese Medicine

基　　金：国家中医药管理局新药基金课题(No.00-01LP30)

摘　　要：目的观察急性心肌梗死(非溶栓者)中医药抢救新方案的疗效并与西药治疗者对比,以确定该方案的可行性。方法将符合观察要求的患者183例随机分为治疗组与对照组。治疗组按急性心肌梗死中医药抢救新方案治疗,对照组予西医常规治疗。观察两组综合疗效、心电图疗效、中医证候疗效及血清心肌酶、MDA、SOD的变化。结果两组综合疗效及心电图疗效相近,而治疗组在中医证候疗效等方面优于对照组。结论本中医药抢救新方案治疗急性心肌梗死临床疗效确切,安全可靠。Objective:To study the effect of treating AMI (non-thrombolytic)based on the new routine emergency plam.Methods:183 patients were divided randomly into two groups.Patients in the treatment group received therapy based on the new routine emergency plam (TCM),and those in the controlled group received therapy of WM.The curative effect,the variations of myocardial,the levels of MDA and SOD were observed.Results:Both groups' comprehensive effects and ECG effects were similar,while the effect of improvement of symptoms in the treatment group was superior to that in the controlled group. Conclussion:It is safe and reliable that treating AMI (non-thrombolytic)based on the new routine emergency plam.

关 键 词：急性心肌梗死 非溶栓 中医药治疗 抢救 速效救心丸 参麦注射液 

分 类 号：R259.422.2[医药卫生—中西医结合]